Epistaxis and Clinic Blood Pressure Values: Is There a Relationship?

IF 3.1 Q2 PERIPHERAL VASCULAR DISEASE
Claudia Lodovica Modesti, Gabriele Testa, Massimo Salvetti, Anna Paini, Michela Riviera, Abramo Bazza, Fabio Bertacchini, Carlo Aggiusti, Davide Lombardi, Vittorio Rampinelli, Cesare Piazza, Maria Lorenza Muiesan
{"title":"Epistaxis and Clinic Blood Pressure Values: Is There a Relationship?","authors":"Claudia Lodovica Modesti, Gabriele Testa, Massimo Salvetti, Anna Paini, Michela Riviera, Abramo Bazza, Fabio Bertacchini, Carlo Aggiusti, Davide Lombardi, Vittorio Rampinelli, Cesare Piazza, Maria Lorenza Muiesan","doi":"10.1007/s40292-024-00669-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Epistaxis is the most common otorhinolaryngological emergency and historically there have been an important debate whether there is a cause-effect relationship with high blood pressure.</p><p><strong>Aim: </strong>This retrospective study explored whether hypertension is a significant risk factor for epistaxis in Emergency Department (ED) patients and examined associations between blood pressure levels and epistaxis episodes.</p><p><strong>Materials and methods: </strong>Two groups were studied: Group A (patients with epistaxis) and Group B (control). Patient characteristics, comorbidities, and medication use were recorded. Blood pressure measurements were taken upon ED arrival and after specialist evaluation. Statistical analyses included descriptive statistics, T-test, χ2 test, and logistic regression.</p><p><strong>Results: </strong>Group A, enrolled from April 2014 to February 2015, included 102 patients, mean age 67, male-female ratio 2:1. Blood pressure on arrival was over 140/90 mmHg in 73%, decreasing to 26% after 30 minutes. Group B, enrolled from May 2023 to August 2023, included 126 patients, mean age 59, male-female ratio 2:1. Blood pressure on arrival was over 140/90 mmHg in 60%, decreasing to 23% after 30 minutes. Both groups showed reduced blood pressure post-evaluation. Logistic regression identified anticoagulant and/or antiplatelet therapy as the main independent risk factor for epistaxis. Age, sex, blood pressure levels, and hypertension did not significantly influence epistaxis occurrence.</p><p><strong>Conclusion: </strong>No significant correlation between hypertension and epistaxis was found. Anticoagulant and/or antiplatelet therapy was the primary independent risk factor, highlighting the importance of considering medication history in evaluating epistaxis.</p>","PeriodicalId":12890,"journal":{"name":"High Blood Pressure & Cardiovascular Prevention","volume":" ","pages":"493-500"},"PeriodicalIF":3.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485013/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"High Blood Pressure & Cardiovascular Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40292-024-00669-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Epistaxis is the most common otorhinolaryngological emergency and historically there have been an important debate whether there is a cause-effect relationship with high blood pressure.

Aim: This retrospective study explored whether hypertension is a significant risk factor for epistaxis in Emergency Department (ED) patients and examined associations between blood pressure levels and epistaxis episodes.

Materials and methods: Two groups were studied: Group A (patients with epistaxis) and Group B (control). Patient characteristics, comorbidities, and medication use were recorded. Blood pressure measurements were taken upon ED arrival and after specialist evaluation. Statistical analyses included descriptive statistics, T-test, χ2 test, and logistic regression.

Results: Group A, enrolled from April 2014 to February 2015, included 102 patients, mean age 67, male-female ratio 2:1. Blood pressure on arrival was over 140/90 mmHg in 73%, decreasing to 26% after 30 minutes. Group B, enrolled from May 2023 to August 2023, included 126 patients, mean age 59, male-female ratio 2:1. Blood pressure on arrival was over 140/90 mmHg in 60%, decreasing to 23% after 30 minutes. Both groups showed reduced blood pressure post-evaluation. Logistic regression identified anticoagulant and/or antiplatelet therapy as the main independent risk factor for epistaxis. Age, sex, blood pressure levels, and hypertension did not significantly influence epistaxis occurrence.

Conclusion: No significant correlation between hypertension and epistaxis was found. Anticoagulant and/or antiplatelet therapy was the primary independent risk factor, highlighting the importance of considering medication history in evaluating epistaxis.

鼻衄与门诊血压值:两者之间有关系吗?
简介:鼻衄是耳鼻喉科最常见的急症,而高血压与鼻衄之间是否存在因果关系,历来是一个重要的争论点。目的:这项回顾性研究探讨了高血压是否是急诊科(ED)患者鼻衄的重要危险因素,并研究了血压水平与鼻衄发作之间的关系:研究分为两组:A组(鼻衄患者)和B组(对照组)。记录患者特征、合并症和用药情况。在到达急诊室时和专家评估后测量血压。统计分析包括描述性统计、T 检验、χ2 检验和逻辑回归:A组于2014年4月至2015年2月入组,包括102名患者,平均年龄67岁,男女比例为2:1。到达时血压超过 140/90 mmHg 的占 73%,30 分钟后降至 26%。B 组从 2023 年 5 月至 2023 年 8 月招募,包括 126 名患者,平均年龄 59 岁,男女比例为 2:1。抵达时血压超过 140/90 mmHg 的患者占 60%,30 分钟后降至 23%。两组患者的血压在评估后都有所下降。逻辑回归确定抗凝剂和/或抗血小板治疗是鼻衄的主要独立风险因素。年龄、性别、血压水平和高血压对鼻衄的发生没有明显影响:结论:高血压与鼻衄之间没有明显的相关性。结论:高血压与鼻衄之间没有明显的相关性,抗凝剂和/或抗血小板治疗是主要的独立风险因素,这突出了在评估鼻衄时考虑用药史的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
3.30%
发文量
57
期刊介绍: High Blood Pressure & Cardiovascular Prevention promotes knowledge, update and discussion in the field of hypertension and cardiovascular disease prevention, by providing a regular programme of independent review articles covering key aspects of the management of hypertension and cardiovascular diseases. The journal includes:   Invited ''State of the Art'' reviews.  Expert commentaries on guidelines, major trials, technical advances.Presentation of new intervention trials design.''Pros and Cons'' or round tables on controversial issues.Statements on guidelines from hypertension and cardiovascular scientific societies.Socio-economic issues.Cost/benefit in prevention of cardiovascular diseases.Monitoring of healthcare systems.News and views from the Italian Society of Hypertension (including abstracts).All manuscripts are subject to peer review by international experts. Letters to the editor are welcomed and will be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信